EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Female fertility preservation for family planning: a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR)

Claudia Massarotti, Danilo Cimadomo, Valentina Spadoni, Alessandro Conforti, Carlotta Zacà, Andrea Roberto Carosso, Alberto Vaiarelli, Roberta Venturella, Amerigo Vitagliano, Andrea Busnelli, Mauro Cozzolino, Andrea Borini

Journal of Assisted Reproduction and Genetics · 2024

DOI: 10.1007/s10815-024-03197-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Assisted Reproduction and Genetics, 2024. Verfasst von Claudia Massarotti und 11 weiteren Autor:innen. Beteiligte Einrichtung: Physiopathology of Human Reproduction, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi, 10, 16132, Genova, Italy. claudia.massarotti@gmail.com. Hauptthemen laut MEDLINE: Fertility Preservation, Reproductive Medicine, Cryopreservation, Ovarian Reserve. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Genova.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This position statement by the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) aims to establish an optimal framework for fertility preservation outside the standard before oncological therapies. Key topics include the role of fertility units in comprehensive fertility assessment, factors impacting ovarian potential, available preservation methods, and appropriate criteria for offering such interventions.

Methods

The SIFES-MR writing group comprises Italian reproductive physicians, embryologists, and scientists. The consensus emerged after a six-month period of meetings, including extensive literature review, dialogue among authors and input from society members. Final approval was granted by the SIFES-MR governing council.

Results

Fertility counselling transitions from urgent to long-term care, emphasizing family planning. Age, along with ovarian reserve markers, is the primary predictor of female fertility. Various factors, including gynecological conditions, autoimmune disorders, and prior gonadotoxic therapies, may impact ovarian reserve. Oocyte cryopreservation should be the preferred method. Women 30–34 years old and 35–39 years old, without known pathologies impacting the ovarian reserve, should cryopreserve at least 12–13 and 15–20 oocytes to achieve the same chance of a spontaneous live birth they would have if they tried to conceive at the age of cryopreservation (63% and 52%, respectively in the two age groups).

Conclusions

Optimal fertility counselling necessitates a long-term approach, that nurtures an understanding of fertility, facilitates timely evaluation of factors that may affect fertility, and explores fertility preservation choices at opportune intervals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertility PreservationReproductive MedicineCryopreservationOvarian ReserveHumansFemaleItalyAdultFamily Planning ServicesOocytesInfertility, FemalePregnancyFertilityCounselingSocieties, Medical

Stichwörter der Autor:innen

Family planningFertility preservationOocytes cryopreservationOvarian reserve

Autor:innen und Institutionen

  • Physiopathology of Human Reproduction, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi, 10, 16132, Genova, Italy. claudia.massarotti@gmail.com.
  • Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health (DINOGMI Department), University of Genova, Genova, Italy. claudia.massarotti@gmail.com.
  • IVIRMA Global Reseach Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
  • IVIRMA Global Research Alliance, 9.Baby, Bologna, Italy.
  • Department of Neuroscience, Reproductive Science and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Obstetrics and Gynecology 1U, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, Sant'Anna Hospital Città della Salute e della Scienza di Torino, University of Torino, Turin, Italy.

Förderung

  • Università degli Studi di Genova

Zitieren

APA

Massarotti, C., Cimadomo, D., Spadoni, V., Conforti, A., Zacà, C., Carosso, A. R., Vaiarelli, A., Venturella, R., Vitagliano, A., Busnelli, A., Cozzolino, M., & Borini, A. (2024). Female fertility preservation for family planning: a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR). Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-024-03197-4

Vancouver

Massarotti C, Cimadomo D, Spadoni V, Conforti A, Zacà C, Carosso AR, et al. Female fertility preservation for family planning: a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR). Journal of Assisted Reproduction and Genetics. 2024. doi:10.1007/s10815-024-03197-4

BibTeX
@article{Massarotti2024,
  author = {Massarotti, Claudia and Cimadomo, Danilo and Spadoni, Valentina and Conforti, Alessandro and Zacà, Carlotta and Carosso, Andrea Roberto and Vaiarelli, Alberto and Venturella, Roberta and Vitagliano, Amerigo and Busnelli, Andrea and Cozzolino, Mauro and Borini, Andrea},
  title = {Female fertility preservation for family planning: a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR)},
  journal = {Journal of Assisted Reproduction and Genetics},
  year = {2024},
  doi = {10.1007/s10815-024-03197-4}
}
Kostenlos starten →